Labiana Health SA
MAD:LAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Labiana Health SA
MAD:LAB
|
ES |
Wall St Price Targets
LAB Price Targets Summary
Labiana Health SA
According to Wall Street analysts, the average 1-year price target for LAB is 9.69 EUR with a low forecast of 9.6 EUR and a high forecast of 9.98 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is LAB's stock price target?
Price Target
9.69
EUR
According to Wall Street analysts, the average 1-year price target for LAB is 9.69 EUR with a low forecast of 9.6 EUR and a high forecast of 9.98 EUR.
What is the Revenue forecast for Labiana Health SA?
Projected CAGR
10%
Over the last 6 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 2 years is 10%.
What is the Gross Profit forecast for Labiana Health SA?
Projected CAGR
11%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 2 years is 11%.
What is the Operating Income forecast for Labiana Health SA?
Projected CAGR
31%
Over the last 6 years, the compound annual growth rate for Operating Income has been 31%. The projected CAGR for the next 2 years is 31%.
What is the Pre-Tax Income forecast for Labiana Health SA?
Projected CAGR
187%
Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 2 years is 187%.
What is the Net Income forecast for Labiana Health SA?
Projected CAGR
70%
Over the last 6 years, the compound annual growth rate for Net Income has been 26%. The projected CAGR for the next 2 years is 70%.
